tiprankstipranks
Trending News
More News >

Sanofi price target lowered to EUR 108 from EUR 121 at Guggenheim

Guggenheim lowered the firm’s price target on Sanofi (SNY) to EUR 108 from EUR 121 and keeps a Buy rating on the shares after the company and partner Regeneron (REGN) announced mixed results from itepekimab’s Phase 3 COPD trials. The firm’s price target change is driven by the removal of itepekimab and SAR441566 forecasts, the analyst noted.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue